Remus Pharmaceuticals Limited (NSE: REMUS)
India
· Delayed Price · Currency is INR 2,232.15
-12.35 (-0.55%)
At close: Jan 21, 2025
Remus Pharmaceuticals Revenue
Remus Pharmaceuticals had revenue of 1.36B INR in the quarter ending September 30, 2024, with 970.16% growth. This brings the company's revenue in the last twelve months to 4.57B. In the fiscal year ending March 31, 2024, Remus Pharmaceuticals had annual revenue of 2.13B with 371.63% growth.
Revenue (ttm)
4.57B
Revenue Growth
+371.63%
P/S Ratio
2.88
Revenue / Employee
95.10M
Employees
48
Market Cap
13.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 2.13B | 1.68B | 371.63% |
| Mar 31, 2023 | 451.32M | 204.15M | 82.59% |
| Mar 31, 2022 | 247.17M | 59.09M | 31.42% |
| Mar 31, 2021 | 188.08M | 63.89M | 51.44% |
| Mar 31, 2020 | 124.19M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,398.38B |
| Tata Consultancy Services | 2,520.82B |
| HDFC Bank | 2,761.06B |
| Bharti Airtel | 1,554.78B |
| ICICI Bank | 1,638.51B |
| Infosys | 1,635.60B |
| State Bank of India | 3,360.28B |
| ITC Limited | 751.35B |